Neuroprotection: Rescue from Neuronal Death in the Brain

Dear Colleagues, The brain is vulnerable to injury. Following injury in the brain, apoptosis or necrosis may occur easily, leading to various functional disabilities. Neuronal death is associated with a number of neurological disorders including hypoxic ischemia, epileptic seizures, and neurodegener...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (408 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 05871nam-a2201477z--4500
001 993546226204498
005 20231214133120.0
006 m o d
007 cr|mn|---annan
008 202201s2021 xx |||||o ||| 0|eng d
035 |a (CKB)5400000000046158 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/76898 
035 |a (EXLCZ)995400000000046158 
041 0 |a eng 
100 1 |a Lee, Bae Hwan  |4 edt 
245 1 0 |a Neuroprotection: Rescue from Neuronal Death in the Brain 
246 |a Neuroprotection 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2021 
300 |a 1 electronic resource (408 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Dear Colleagues, The brain is vulnerable to injury. Following injury in the brain, apoptosis or necrosis may occur easily, leading to various functional disabilities. Neuronal death is associated with a number of neurological disorders including hypoxic ischemia, epileptic seizures, and neurodegenerative diseases. The brain subjected to injury is regarded to be responsible for the alterations in neurotransmission processes, resulting in functional changes. Oxidative stress produced by reactive oxygen species has been shown to be related to the death of neurons in traumatic injury, stroke, and neurodegenerative diseases. Therefore, scavenging or decreasing free radicals may be crucial for preventing neural tissues from harmful adversities in the brain. Neurotrophic factors, bioactive compounds, dietary nutrients, or cell engineering may ameliorate the pathological processes related to neuronal death or neurodegeneration and appear beneficial for improving neuroprotection. As a result of neuronal death or neuroprotection, the brain undergoes activity-dependent long-lasting changes in synaptic transmission, which is also known as functional plasticity. Neuroprotection implying the rescue from neuronal death is now becoming one of global health concerns. This Special Issue attempts to explore the recent advances in neuroprotection related to the brain. This Special Issue welcomes original research or review papers demonstrating the mechanisms of neuroprotection against brain injury using in vivo or in vitro models of animals as well as in clinical settings. The issues in a paper should be supported by sufficient data or evidence. Prof. Bae Hwan Lee Guest Editor 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
653 |a global cerebral ischemia 
653 |a amiloride 
653 |a sodium-hydrogen exchanger-1 
653 |a zinc 
653 |a neuronal death 
653 |a neuroprotection 
653 |a neurodegenerative disorder 
653 |a choline acetyltransferase (ChAT) 
653 |a trimethyltin (TMT) 
653 |a bean phosphatidylserine (Bean-PS) 
653 |a brain-derived neurotrophic factor 
653 |a moderate hypoxia 
653 |a physical exercise 
653 |a psychomotor function 
653 |a reaction time 
653 |a cortisol 
653 |a catecholamines 
653 |a nitrite 
653 |a endotheline-1 
653 |a lactate 
653 |a pyridoxine deficiency 
653 |a ischemia 
653 |a gerbil 
653 |a homocysteine 
653 |a cell death 
653 |a glia 
653 |a neurogenesis 
653 |a N-acetyl-l-cysteine 
653 |a transient receptor potential melastatin 2 
653 |a neurodegeneration 
653 |a Alzheimer's disease 
653 |a metabolic disease 
653 |a adiponectin 
653 |a insulin 
653 |a antioxidants 
653 |a stroke 
653 |a preventive gene therapy 
653 |a adenoviral vector 
653 |a VEGF 
653 |a GDNF 
653 |a NCAM 
653 |a human umbilical cord blood mononuclear cells 
653 |a antioxidant 
653 |a brain 
653 |a neurodegenerative disease 
653 |a oxidative stress 
653 |a PGC-1α 
653 |a vascular endothelial growth factor 
653 |a vascular endothelial growth factor receptor 2 
653 |a PI3K/AKT 
653 |a MEK/ERK 
653 |a status epilepticus 
653 |a hippocampus 
653 |a middle cerebral artery occlusion 
653 |a reperfusion injury 
653 |a lipid emulsion 
653 |a excitotoxicity 
653 |a apoptosis 
653 |a GPR4 receptor 
653 |a MPP+ 
653 |a Parkinson's disease 
653 |a CRISPR/cas9 
653 |a ischemic stroke 
653 |a blood brain barrier 
653 |a nanoparticle-based drug delivery 
653 |a brain targeting 
653 |a BDNF 
653 |a miRNAs 
653 |a synaptic plasticity 
653 |a depression 
653 |a glioblastoma 
653 |a astrocytes 
653 |a astrocytic networks 
653 |a connexin 43 
653 |a calcium activity 
653 |a neural injury 
653 |a nimodipine 
653 |a subarachnoid haemorrhage 
653 |a acid-sensing ion channels 
653 |a oxygen-glucose deprivation 
653 |a liver growth factor 
653 |a inflammation 
653 |a microglia 
653 |a Tg2576 transgenic mice 
653 |a amyloid-beta 
653 |a oculomotor system 
653 |a trophic factors 
653 |a motoneurons 
653 |a axotomy 
653 |a amyotrophic lateral sclerosis 
653 |a electroneutral transport 
653 |a cation-chloride cotransporters 
653 |a KCCs 
653 |a NKCCs 
653 |a WNK-SPAK/OSR1 
653 |a ascorbic acid 
653 |a aging 
653 |a organotypic hippocampal slice culture 
776 |z 3-0365-1994-7 
776 |z 3-0365-1995-5 
700 1 |a Lee, Bae Hwan  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:43:15 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338190450004498&Force_direct=true  |Z 5338190450004498  |b Available  |8 5338190450004498